Commercial ULF MRI Scanner
Final product for commercial sale and deployment
Pre-commercialTargeting FDA 510(k) clearance Aug 2028
Key Facts
Indication
Final product for commercial sale and deployment
Phase
Pre-commercial
Status
Targeting FDA 510(k) clearance Aug 2028
Company
About Chipiron
Chipiron is a pioneering medtech startup building a disruptive, ultra-low-field (<10 mT) full-body MRI scanner designed to be lightweight, affordable, and operable without shielded rooms or specialized technicians. The company has secured significant non-dilutive grants and equity financing, including a $17M Series A and a major EIC Accelerator award, validating its ambitious vision. With a roadmap targeting first in-vivo images in 2025 and FDA clearance in 2028, Chipiron aims to revolutionize medical imaging by making MRI screening and image-guided therapies accessible on a global scale.
View full company profile